Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities

MS Tretiakova - Advances in Anatomic Pathology, 2022 - journals.lww.com
Translocation renal cell carcinoma (tRCC) with TFE3 gene rearrangements has been born
as a distinct entity 20 years ago. These relatively rare tumors were notable among other …

Immunohistochemistry for the diagnosis of renal epithelial neoplasms

M Akgul, SR Williamson - Seminars in Diagnostic Pathology, 2022 - Elsevier
Despite the increasing number of newly identified renal neoplasms, the diagnosis of renal
cell carcinoma (RCC) can usually be reached with careful histologic examination and a …

Xp11. 2 translocation renal cell carcinoma with TFE3 rearrangement: Distinct morphological features and prognosis with different fusion partners

Y Ge, X Lin, Q Zhang, D Lin, L Luo, H Wang… - Frontiers in …, 2021 - frontiersin.org
Background: Renal cell carcinoma associated with Xp11. 2 translocation/TFE3 gene fusion
is a rare and new subtype of RCC and is classified by WHO in 2004. Since then, multiple …

Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey

M Akgul, SR Williamson, D Ertoy, P Argani… - Journal of clinical …, 2021 - jcp.bmj.com
Transcription factor E3-rearranged renal cell carcinoma (TFE3-RCC) has heterogenous
morphologic and immunohistochemical (IHC) features. 131 pathologists with genitourinary …

Classification of renal cell tumors–current concepts and use of ancillary tests: recommendations of the Brazilian Society of Pathology

DA Athanazio, LS Amorim, IW da Cunha… - Surgical and …, 2021 - Springer
Classification of renal cell carcinomas has become more challenging. The 2016 WHO
classification included 14 different subtypes and 4 emerging/provisional entities, and recent …

Identification of key differentially expressed mRNAs, miRNAs, lncRNAs, and circRNAs for Xp11 translocation renal cell carcinoma (RCC) based on Whole …

C Deng, C Wei, Y Hou, M Xiong, D Ni, Y Huang… - Genes, 2023 - mdpi.com
We carried out whole transcriptome sequencing (WTS) on the tumor and the matching
adjacent normal tissues from five patients having Xp11 translocation renal cell carcinoma …

Clinicopathologic, treatment and prognosis study of 46 Xp11. 2 translocation/TFE3 gene fusion renal cell carcinomas

J Zhou, L Zhao, Z Yang, Y Chen, X Wu, W Xue - BMC urology, 2022 - Springer
Purpose To report the clinicopathological features and mid-to long-term oncologic results of
Xp11. 2 translocation/transcription factor E3 (TFE3) gene fusion renal cell carcinomas …

Gender difference analysis of Xp11. 2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review

W Zhuang, N Liu, H Guo, C Zhang, W Gan - BMC urology, 2020 - Springer
Background Xp11. 2 translocation renal cell carcinoma (tRCC) is recently recognized. As
Xp11. 2 tRCC involved gene translocation and fusion in X chromosome and the number of X …

Establishment and Characterization of a TFE3-rearranged Renal Cell Carcinoma Cell Line (FU-UR-2) With the PRCC-TFE3 Fusion Transcript

M Ishiguro, T Fukushige, H Iwasaki - Anticancer Research, 2023 - ar.iiarjournals.org
Background/Aim: Xp11. 2-RCC was classified into molecularly defined renal carcinomas
and named TFE3-rearranged renal cell carcinoma (TFE3-rRCC) in the 2022 World Health …

Xp11. 2 translocation renal cell carcinoma: Clinical characteristics and potential prognostic predictors

J Dong, W Xu, Z Ji, B Pan - Disease markers, 2021 - Wiley Online Library
Background. Xp11. 2 translocation renal cell carcinoma, a rare malignancy, has a higher
prevalence in children than in adults. It is relatively indolent in children but manifests with an …